Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Browse Other Projects on Experiment
Related Projects
Developing a novel oxysterol antibiotic to combat drug-resistant tuberculosis
Drug-resistant tuberculosis (TB) is a consistently growing threat to global health. We have developed Oxy291...
Synthesis of a Kidney Cancer Drug
We need to prepare a 75 mg sample of our anti-kidney cancer drug for testing. The sample was requested by...
From Minerals to Medicines: A New Technology for Heavy Metal Pollution Remediation
This is the first part of a multi-phase experiment in which I will prove that substances isolated from plant...